Listed by the USPTO as SIPPEL, RACHEL T
Tech Center 3700 • Art Units: 3636 3771 3785
This examiner grants 52% of resolved cases
SIPPEL, RACHEL T examines in USPTO tech center 3700 and art unit 3636. Across 813 resolved cases, the allowance rate is 52.5%, and the median time to allowance is 1409 days. The 58.2% interview lift is substantial in this record, indicating that interviews may be an important tool for improving prosecution outcomes.
The leading companies are James L Orrington Ii D D S P C, Mallinckrodt Pharmaceuticals Ireland Limited, and Fisher & Paykel Healthcare Limited. The listed firms are STITES & HARBISON PLLC, Arch & Lake LLP, and Carlson, Caspers, Vandenburgh & Lindquist, P.A. Practitioners should account for the recorded timing while considering interviews as a central response option.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18296049 | REPLACEABLE FILTER SYSTEMS FOR MECHANICAL VENTILATION | Non-Final OA | Covidien LP |
| 18315102 | RESPIRATOR DEVICES AND FOLDING PATTERNS FOR RESPIRATOR FILTERS | Non-Final OA | Honeywell Safety Products USA, Inc. |
| 18268205 | LOAD DISTRIBUTION DEVICE FOR IMPROVING THE MOBILITY OF THE CENTER OF MASS OF A USER DURING COMPLEX MOTIONS | Final Rejection | Wistron Corporation |
| 18117917 | SYSTEMS AND METHOD FOR DELIVERY OF THERAPEUTIC GAS TO PATIENTS, IN NEED THEREOF, RECEIVING BREATHING GAS FROM A VENTILATOR THAT VARIES AT LEAST PRESSURE AND/OR FLOW USING ENHANCED THERAPEUTIC GAS (NO) FLOW MEASUREMENT | Final Rejection | Mallinckrodt Pharmaceuticals Ireland Limited |
| 18109506 | SYSTEMS AND METHODS FOR INTELLIGENT GAS SOURCE MANAGEMENT | Non-Final OA | Mallinckrodt Pharmaceuticals Ireland Limited |
| 18467576 | NASAL CANNULA WITH FLOW RESTRICTOR | Final Rejection | Fisher & Paykel Healthcare Limited |
| 17442321 | MUFFLER | Final Rejection | Fisher & Paykel Healthcare Limited |
| 18312837 | COMPRESSION GARMENT | Final Rejection | Koya Medical, Inc. |
| 18559089 | SYSTEM AND METHOD FOR LIMB COMPRESSION | Non-Final OA | Roger TSANG |
| 18001288 | HIGH QUALITY MASK | Final Rejection | NANA PRODUCTS LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy52.5% of resolved applications examined by Rachel T Sippel were allowed (813 resolved cases), compared with 64.5% across Art Unit 3636 over the last five years.
This examiner's interview lift is +58.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Rachel T Sippel took 1,409 days on average from filing to allowance.
Rachel T Sippel examines applications in Art Unit 3636 in Tech Center 3700 (Medical Devices & Mechanical Engineering).